Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Blood cancers, Children's cancers, Leukaemia
Results
Phase 1/2
This study used gene therapy to treat children with acute lymphoblastic leukaemia (ALL).
The study was for children and young people up to and including the age of 18. We use the term ‘you’ in this summary, but of course if you are a parent, we are referring to your child.
Recruitment start: 2 May 2012
Recruitment end: 4 November 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Persis Amrolia
Bloodwise
Children with Leukaemia
Department of Health
EU Framework 6
Moulton Charitable Foundation
University College London (UCL)
Last reviewed: 6 June 2017
CRUK internal database number: 7441